Jin Medical (ZJYL) stock price, chart and financials
Price chart
Financials
- Revenue (quarter)
- $8.9M
- Gross margin
- 30.62%
- Net income (quarter)
- −$209,004.00
- Net income growth (year over year)
- −2422.78%
- Net margin
- 5.90%
- Return on equity
- 4.03%
- Book value per share
- $3.87
- Price to book
- 10.60
- Debt to assets
- 46.01%
Company profile
Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.
Frequently asked questions
Is Jin Medical (ZJYL) profitable?
Yes. Jin Medical earned $1.2M in net income over the trailing twelve months, a net margin of 5.90%.
How much revenue does Jin Medical (ZJYL) make?
Jin Medical generated $19.7M in revenue over the trailing twelve months, down 9.74% year over year.
What is ZJYL's P/E ratio?
Jin Medical trades at 272.5 times trailing twelve-month earnings, on an EPS of $0.20.
How do I buy stock in Jin Medical (ZJYL)?
ZJYL trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
